期刊文献+

基于类风湿关节炎患者报告的临床结局测量量表的初步构建 被引量:25

Preliminary Construction of Questionnaire Based on Rheumatoid Arthritis Patients-Reported Outcomes
原文传递
导出
摘要 目的建立基于类风湿关节炎(RA)患者报告的临床结局(PRO)测量量表,从患者报告的角度为RA临床疗效评价提供一个新的方法。方法采用文献资料查询、病历回顾、临床访谈、头脑风暴法、专家咨询等构建量表条目,确立躯体状态、心理状态及社会健康3方面域体系,并确立量表条目;参考患者日常就诊时描述的常用语言,结合国内外成熟的中文版量表的条目,形成PRO量表;现场调查获得137例有效测试数据,对量表信度、效度进行统计分析。结果信度分析中内部一致性信度克朗巴赫系数α为0.878,折半信度系数为0.793;效度分析中,利用主成分的方法进行因子分析,得出躯体功能和社会健康、心理状态、躯体功能及躯体感觉4个领域。条目分析中,各条目区分度较好,能区分所调查条目的不同程度。结论本量表信度、效度较高,可用于类风湿关节炎患者报告的临床疗效评价。 Objective To compile the measurement scale based on patient-reported outcomes (PRO) of rheumatoid arthritis(RA) patients to provide a new way of evaluation of clinical effect from the viewpoint of patients' report. Methods Literature consulting, case reviewing, talking with patients, brain storming, and consulting to experts were adopted to establish domain system containing body status, mental status and social health and then set up the items. The patients' language was taken as reference and the mature items used in China and abroad were taken in combination for the compilation of PRO Scale. We obtained the valid data from 137 patients in the field investigation and did the statistical analysis on the reliability and validity of the scale. Results In the reliability, the Cronbach's Alpha coeffecient was 0. 878, and the coeffecient of split-hall reliability was0. 793. In the validity, the main ingredients were used for the factor analysis and the four fields were obtained, including body function, social health, mental status, and body function and somatosensory. The item analysis showed a good item discrimination, able to distinguish the different degrees of investigated items. Conclusion The very PRO Scale is high in reliability and validity and can be used to evaluate the therapeutic effect of RA patients.
出处 《中医杂志》 CSCD 北大核心 2009年第6期503-506,共4页 Journal of Traditional Chinese Medicine
基金 国家科技部基础平台建设项目(2004DEA71040)
关键词 患者报告结局 类风湿关节炎 量表 临床疗效评价 Patient-reported outcomes(PRO) Rheumatoid arthritis(RA) Questionnaire Clinical efficacy evaluation
  • 相关文献

参考文献6

  • 1Pincus T, Bergman MJ, Yazici Y, et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures[J]. Rheumatology, 2008,47 (3) : 345 - 349.
  • 2PincusT, Segurado OG. Most visits of mostpatients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count[J]. Ann Rheum Dis, 2006, 65(6) :820- 822.
  • 3Pincus T, Amara I, Segurado OG, et al. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials[J]. J Rheumatol, 2008, 35(2) :201 - 205.
  • 4U. S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, FDA Center for Biologics Evaluation and Research, FDA Center for Devices and Radiological Health. Guidance for inductory; Patient-reported outcome measures: use in medical product development to support labeling claims:draft guidance[J]. Health Qual Life Outcome, 2006, (4) : 79.
  • 5Kirwan J, Heiberg T, Hewlett S,et al. Outcomes from the Patient Perspective Workshop at OMERACT 6 [ J ]. J Rheumatol, 2003,30 (4) : 868 - 872.
  • 6Kirwan JR, Hewlett SE, Heiberg T, et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis progress at OMERACT 7[J]. J Rheumatol, 2005,32 (11 ) : 2250 - 2256.

同被引文献283

引证文献25

二级引证文献253

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部